Richard Lindley's Publications

About Richard Lindley's Publications

Professorial Fellow
  • MBBS,
  • MD,
  • FRCP(Edin),
  • FRACP

  • WHY DO CHINESE PATIENTS HAVE BETTER OUTCOME AFTER ICH? INTERACT2 RESULTS

    Date published:

  • CLINICAL PROGNOSIS OF FLAIR HYPERINTENSE ARTERIES IN ISCHEMIC STROKE PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS

    Date published:

  • REGIONAL DIFFERENCES IN EARLY BP MANAGEMENT AFTER ACUTE STROKE IN INTERNATIONAL RANDOMIZED CONTROLLED TRIALS OF 5000 PATIENTS

    Date published:

  • Sex differences in treatment and outcome after stroke

    Neurology Date published:

  • Interaction of Blood Pressure Lowering and Alteplase Dose in Acute Ischemic Stroke: Results of the Enhanced Control of Hypertension and Thrombolysis Stroke Study

    Cerebrovascular Diseases Date published:

  • Disparities in Antihypertensive Prescribing After Stroke

    Stroke Date published:

  • Early mobilization and quality of life after stroke

    Neurology Date published:

  • Dementia treatment: The need for a paradigm shift

    Australasian Journal on Ageing Date published:

  • Impact of Evidence-Based Stroke Care on Patient Outcomes: A Multilevel Analysis of an International Study

    Journal of the American Heart Association Date published:

  • Caregiver-Delivered Stroke Rehabilitation in Rural China

    Stroke Date published:

  • Who will benefit more from low-dose alteplase in acute ischemic stroke?

    International Journal of Stroke Date published:

  • Determinants of Early Versus Delayed Neurological Deterioration in Intracerebral Hemorrhage

    Stroke Date published:

  • Infratentorial Intracerebral Hemorrhage

    Stroke Date published:

  • The effect of a multidisciplinary co-management program for the older hip fracture patients in Beijing: a “pre- and post-” retrospective study

    Archives of Osteoporosis Date published:

  • Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial

    The Lancet Date published:

  • Canagliflozin and Stroke in Type 2 Diabetes Mellitus

    Stroke Date published: